T. cruzi Incidence Study in Blood Donors and its Implications for One-time Testing of Blood Donors - UCM265675.pdf

Blood Products Advisory Committee Meeting
August 2, 2011
Gaithersburg, MD
Topic I: T. cruzi Incidence Study in Blood Donors and its Implications for One-time Testing of Blood Donors
Issue: FDA seeks the Committee’s assessment of the data in the Incidence Study to support one-time testing of blood donors for evidence of T. cruzi infection.
full-text ►
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM265675.pdf

BLOOD PRODUCTS ADVISORY COMMITTEE
101st Meeting, August 2-3, 2011
The Hilton Washington DC North/Gaithersburg
620 Perry Parkway
Gaithersburg, MD 20877
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM265673.pdf

http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM265674.pdf